Is sinus rhythm associated with fewer heart failure symptoms : insights from the AFFIRM trial?
Patients in the rhythm control arm had fewer HF symptoms than those in the rate control arm. Stable sinus rhythm was associated with the best functional status. Patients who are the most symptomatic in AF but are unable to maintain normal sinus rhythm if treated by the means used in the AFFIRM trial may be candidates for other treatment options, such as ablation.
Rebamipide is a possible candidate drug for treatment of cornea and conjunctival epithelial damage due to its mucin-like substance increasing action, for instance, in the treatment of dry eye disease.